- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06363526
Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies. (DMDrespy2024)
Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
Study Overview
Status
Intervention / Treatment
Detailed Description
It will be done 4 times a week for a period of 5 weeks, for a duration of 55-60 minutes (20 sessions), with an intensity adapted to the characteristics of each participant. An intervention program will be used based on respiratory muscle training exercises, upper limb strength work, yoga, diaphragmatic awareness exercises, always trying to do them through the use of games, and even try to include exercises that use motor imagery.
It is advisable during intervention program to have a playful environment stimulated for the children, and that the intervention program is carried out and stimulated through videos and therapeutic teaching to the caregivers in the first evaluation session, as well as with a weekly follow-up using WhatsApp as forms of communication, or a telephone call to ensure correct follow-up of the intervention program.
It is essential that to carry out the intervention, videos obtained from YouTube, own videos prepared to explain the exercises in a playful way applied to children, and even other applications such as Spotify to work with music, will be used, being offered in case of Zoom calls may be necessary to help optimally resolve doubts that arise when carrying out the program by video call.
At the end of the respiratory digital physiotherapy program, variables will be evaluated by the principal examiner.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Málaga, Spain
- Rocío Martín-Valero
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants with Duchenne muscular dystrophy and patients with Becker muscular dystrophy will be chosen.
- Aged between 5 and 20 years.
- Child who could walk and follow the intervention program, and were diagnosed according to the International Classification of Diseases, 10 Revision. code (G71-01); and who had an NSSA score greater than 20.
Exclusion Criteria:
- Patients who present associated heart disease.
- Patients who presentor fractures, a heart rate greater than 120 beats per minute, or an oxygen saturation less than 89% will be excluded.
- Participants who do not have the capacity to have internet at home to perform the intervention, as well as all patients whose caregivers did not agree to sign the informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients with Duchenne muscular dystrophy and Becker muscular dystrophy
A group of 12 patients with Duchenne muscular dystrophy and Becker muscular dystrophy that will be following a digital respiratory physiotherapy program.
|
A 4 times a week for a period of 5 weeks will be done, for a duration of 55-60 minutes (20 sessions), with an intensity adapted to the characteristics of each participant. Moreover, an intervention program will be used based on respiratory muscle training exercises, upper limb strength work, yoga, diaphragmatic awareness exercises, always trying to do them through the use of games, and even try to include exercises that use motor imagery. The intervention program is carried out and stimulated through videos and therapeutic teaching to the caregivers in the first evaluation session, as well as as well as with a weekly follow-up using WhatsApp or Zoom as forms of communication, or a telephone call to ensure correct follow-up of the intervention program. Moreover, YouTube videos, own videos prepared by the physiotherapy will be used to help optimally resolve doubts that arise when carrying out the program by video call. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analyze the improvement of the forced vital capacity (FVC).
Time Frame: Baseline, up to 5 weeks.
|
Forced vital capacity is a respiratory parameter which is obtained from spirometry and which provides objective, valid information.
It will be performed using spirometry before and after the digital respiratory intervention program.
The spirometer that will be used is the "EasyOne Air Spirometer that complies with ISO 26782 standards, following the national spirometric recommendations of the ATS/ERS 2019.
|
Baseline, up to 5 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perform an anthropometric study of the patient's characteristics, taking into account weight; and also a general physical examination.
Time Frame: Baseline, up to 5 weeks.
|
An anthropometric study of the patient's characteristics will be carried out, taking into account age, weight, as well as the average values that should be established based on age; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program. The weight will be check by "SECA 700 MECHANICAL COLUMN SCALE WITH SECA 220 STADIOMETER", and the height will be analyze by a measuring tape. |
Baseline, up to 5 weeks.
|
|
Perform an anthropometric study of the patient's characteristics, taking into account age.
Time Frame: Baseline, up to 5 weeks.
|
An anthropometric study of the patient's characteristics will be carried out, taking into account age, as well as the average values that should be established based on age; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program.
|
Baseline, up to 5 weeks.
|
|
Perform an anthropometric study of the patient's characteristics, taking into account height.
Time Frame: Baseline, up to 5 weeks.
|
An anthropometric study of the patient's characteristics will be carried out, taking into account height, as well as the average values that should be established based on age; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program.
|
Baseline, up to 5 weeks.
|
|
Perform an anthropometric study of the patient's characteristics, taking into account sex.
Time Frame: Baseline, up to 5 weeks.
|
An anthropometric study of the patient's characteristics will be carried out, taking into account height, as well as the average values that should be established based on sex; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program.
|
Baseline, up to 5 weeks.
|
|
Examine changes in forced expiratory pressure
Time Frame: Baseline, up to 5 weeks.
|
Forced expiratory pressure is a respiratory parameter obtained through spirometry, which provides important information about the patient's respiratory status.
Measuring it will be done with the same characteristics as that previously mentioned in the FVC.
|
Baseline, up to 5 weeks.
|
|
Analyze changes in maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP).
Time Frame: Baseline, up to 5 weeks.
|
Changes in the strength of the inspiratory and expiratory muscles will be assessed using a pressure meter with a reading range of ±300 cm H20 and an accuracy of 3% (MicroRPM® model, Vyaire Medical GmbH, Hoechberg, Germany) following the national recommendations of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) (16).
|
Baseline, up to 5 weeks.
|
|
Check if there are changes in the sniff nasal inspiratory pressure (SNIP)
Time Frame: Baseline, up to 5 weeks.
|
The existence of changes in the diaphragm force index is assessed, measuring it in exactly the same way as the MIP and PEM.
|
Baseline, up to 5 weeks.
|
|
Evaluate the fatigue in patients using an EPInfant test.
Time Frame: Baseline, up to 5 weeks.
|
The amount of effort the child perceives during the sessions is assessed.
It shows 11 descriptors numbered from 0 to 10 and 5 verbal descriptors located every 2 levels of the numbered descriptors, along with a drawing of a child doing physical activity in an increasing manner, increasing in intensity from left to right.
The higher the numerical value, the worse the result is considered.
|
Baseline, up to 5 weeks.
|
|
Evaluate the quality of life of patients using a scale called "Kindscreen-52".
Time Frame: Baseline, up to 5 weeks.
|
52-item scale carried out in Ravens-Sieberer U and validated in Spanish by Rajmil L, which assesses physical and psychological well-being, mood and emotions, self-perception, autonomy and relationship with friends and social life. .
The scores were transformed into a scale from 0 to 100 to facilitate their interpretation: the higher the score, the higher HRQoL.
|
Baseline, up to 5 weeks.
|
|
North Star Ambulatory Assessment o NSAA
Time Frame: Baseline, up to 5 weeks.
|
Designed to capture the construct of ambulatory function in DMD.
17-item scale that grades performance of various functional skills on a scale from 0 (unable), 1 (completes independently but with modifications), and 2 (completed without compensation).
Total score 0 - 34 with a higher score denoting a higher level of function.
It includes two timed tests.
Timed rise from floor (RFF) and timed 10 metre walk / run test (10MWR).
Validated and regularly used in clinical trials as well as clinic.
Well understood by families.
The best score is 34 points.
|
Baseline, up to 5 weeks.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Rocío Martín-Valero, PhD, University of Malaga
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UMalagaDRIP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscular Dystrophy
-
Avidity Biosciences, Inc.RecruitingFacioscapulohumeral Muscular Dystrophy | FSHD | Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) | Facio-Scapulo-Humeral Dystrophy | FSHD - Facioscapulohumeral Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral... and other conditionsUnited States, Denmark, Spain, Canada, United Kingdom, Italy, Germany, France, Japan, Netherlands
-
Avidity Biosciences, Inc.CompletedMuscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, Canada, United Kingdom
-
Avidity Biosciences, Inc.Active, not recruitingMuscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, Canada, United Kingdom
-
FSHD SocietyRecruitingFacioscapulohumeral Muscular Dystrophy | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facioscapulohumeral Muscular Dystrophy (FSHD) | FSHD - Facioscapulohumeral Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | Facioscapulohumeral Muscular Dystrophy 2 | FSH Muscular Dystrophy and other conditionsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBecker Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy | Limb-Girdle Muscular DystrophyUnited States
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedMuscular Dystrophies | Duchenne Muscular Dystrophy | Becker Muscular Dystrophy | Limb-Girdle Muscular DystrophyUnited States
-
IRCCS Eugenio MedeaRecruitingMuscular Dystrophies | Becker Muscular Dystrophy | Limb Girdle Muscular Dystrophy | Facio-Scapulo-Humeral DystrophyItaly
-
Dyne TherapeuticsRecruitingMuscular Dystrophies | Muscular Dystrophy, Duchenne | Duchenne Muscular Dystrophy (DMD) | Muscular Dystrophy, Duchenne and Becker Types | Genetic Disease, X-Linked | Genetic Disease, Inborn | DMD | Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Muscular Dystrophy (DMD) | Muscular Dystrophies... and other conditionsUnited States
-
Massachusetts General HospitalUniversity of Pittsburgh; Boston Children's Hospital; Brigham and Women's Hospital and other collaboratorsRecruitingDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | Myotonic Dystrophy | Facioscapulohumeral Muscular DystrophyUnited States
-
West China Second University HospitalNot yet recruitingMuscular Dystrophy | Muscular Dystrophy, Duchenne | Muscular Dystrophy (DMD) | Muscular Dystrophy, BeckerChina
Clinical Trials on Digital respiratory intervention program
-
National Health Research Institutes, TaiwanCompletedBurnout, Professional | Stress, Psychological | Caregivers | Caregivers BurnoutTaiwan
-
St. Olavs HospitalNorwegian University of Science and TechnologyRecruitingMental Disorder | Patient Education | Mental Health IssueNorway
-
Lumos Labs, Inc.Active, not recruitingCognition | Brain Health | Brain Function | Brain StructureUnited States
-
Evidation HealthSanofi Pasteur, a Sanofi CompanyCompleted
-
George Washington UniversityKing's College London; Duke University; Medical Research Council; University of... and other collaboratorsCompleted
-
Cairo Universitymai albanaRecruitingTime Management | Problematic Smartphone Use | Digital DistractionSaudi Arabia
-
Umeå UniversityVästerbotten County Council, SwedenRecruitingRadiography | DentistrySweden
-
Idaho State UniversityNot yet recruitingExperimental Video Games | Behavioral Assessment
-
Giresun UniversityRecruitingDigital Literacy | Digital Privacy | Online Privacy AwarenessTurkey (Türkiye)
-
Ataturk UniversityNot yet recruiting